JY
ARLZ

Jeff Yass’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Jeff Yass’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39,211
Closed -$14K – 10991
2018
Q2 		$14K Sell
39,211
-82,597
-68% -$67.8K ﹤0.01% 9455
2018
Q1 		$183K Sell
121,808
-72,814
-37% -$127K ﹤0.01% 8389
2017
Q4 		$277K Buy
194,622
+95,335
+96% +$156K ﹤0.01% 7725
2017
Q3 		$227K Buy
99,287
+1,341
+1% +$1.79K ﹤0.01% 7826
2017
Q2 		$132K Buy
97,946
+40,615
+71% +$58.7K ﹤0.01% 8555
2017
Q1 		$123K Sell
57,331
-49,581
-46% -$186K ﹤0.01% 8305
2016
Q4 		$471K Sell
106,912
-123,821
-54% -$588K ﹤0.01% 7124
2016
Q3 		$1.12M Buy
230,733
+167,964
+268% +$766K ﹤0.01% 4600
2016
Q2 		$207K Sell
62,769
-66,980
-52% -$253K ﹤0.01% 7560
2016
Q1 		$461K Buy
+129,749
New +$669K ﹤0.01% 6554

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Jeff Yass's ARLZ Position: Q3 2018 in Review

Jeff Yass sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 39,211 shares — an estimated $14K sold.

Jeff Yass first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1.12M in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Jeff Yass reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Jeff Yass sold 39,211 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $14K.
  • Jeff Yass first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Jeff Yass's Aralez Pharmaceuticals Inc. position peaked at $1.12M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.